Recruiting

Hiya Kids Multivitamin

Sponsor:

Hiya Health

Code:

NCT07893626

Conditions

Nutrient Gap in Children

Pediatric Health and Well-Being

Immune Health

Growth and Development

Energy Levels

Eligibility Criteria

Sex: All

Age: 3 - 12

Healthy Volunteers: Accepted

Interventions

Hiya Kids Daily Multivitamin

Study Details

Brief summary:

This is a single-group, open-label, fully decentralized (virtual) clinical trial evaluating the effects of the Hiya Kids Daily Multivitamin on parent/caregiver-perceived growth and development, immune health, daily energy, focus, and overall well-being in generally healthy children aged 3-12 years over an eight-week supplementation period.

Enrolled children will receive one Hiya Kids Daily Multivitamin chewable tablet administered once daily with the first meal of the day for eight consecutive weeks. Parents or caregivers will complete study-specific questionnaires at Baseline, Week 2, Week 4, Week 6, and Week 8, and a product acceptability assessment at Week 8. All assessments are completed remotely via the study platform. Forty participants will be enrolled.

Conditions

Nutrient Gap in Children

Pediatric Health and Well-Being

Immune Health

Growth and Development

Energy Levels

Study ID

NCT07893626

Start date

Aug 31, 2026

Status verified date

Oct, 2026

Completion date

Oct 26, 2026

Anticipated

Primary completion date

Oct 26, 2026

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 3 - 12

Healthy Volunteers: Accepted

Inclusion Criteria:

  • Child aged 3-12 years at enrollment.
  • Be male or female.
  • Parent/caregiver seeking support for a child in at least one of the following areas: difficulties with focus or attention, low or inconsistent daily energy levels, growth and development, or nutrient gaps associated with selective or picky eating.
  • Any child who is generally healthy - does not live with any uncontrolled chronic disease.
  • Parent or caregiver willing and able to provide written informed consent and obtain age-appropriate assent from their child if the child is 7 years or older.
  • Parent or caregiver willing to administer one Hiya Kids Daily Multivitamin chewable tablet once daily, with the first meal of the day, for eight consecutive weeks and complete questionnaires at Baseline, Week 2, Week 4, Week 6, and Week 8.
  • Anyone willing to refrain from introducing any new prescription medications, wellness products, supplements, or herbal remedies into their child's routine during the test period.
  • If the child has been taking any other products, supplements, or herbal remedies, they have been taking these consistently for at least three months.
  • Child has had a stable diet and sleep schedule for at least four weeks prior to the study.
  • Resides in the United States.

Exclusion Criteria:

  • Any child with a neurodevelopmental condition or developmental delay, including autism spectrum disorder, intellectual disability, language disorder, uncontrolled anxiety or mood disorder, or dyslexia.
  • Any child who has planned changes to school schedule, sleep routines, or behavioral therapies during the study duration.
  • Previous diagnosis of Attention-deficit hyperactivity disorder (ADHD).
  • Any child currently undergoing any assessments for suspected neurodevelopmental conditions or developmental delay.
  • Any child with any known allergies or hypersensitivities to any supplement product ingredients.
  • Any child with any chronic health conditions that could impact their participation in this study, such as cancer, mental health disorders, a history of serious illness in the last three months, or planned surgery during the study period.
  • Any child currently testing, or planning on starting in the next eight weeks, a product for another research study.

Study Design

Enrollment

40 participants

Anticipated

Intervention Model

Single group

Primary purpose

Treatment

Interventions and Outcome Measures

Arms

experimental: Hiya Kids Daily Multivitamin Arm

Interventions

Hiya Kids Daily Multivitamin

Enrolled children will receive one Hiya Kids Daily Multivitamin chewable tablet administered once daily with the first meal of the day for eight consecutive weeks. Parents or caregivers will complete study-specific questionnaires at Baseline, Week 2, Week 4, Week 6, and Week 8, and a product acceptability assessment at Week 8.

Primary outcome measure

  • Change in Parent/Caregiver-Perceived Growth and Development [ Time Frame: Baseline, Week 2, Week 4, Week 6, and Week 8 ]
  • Change in Parent/Caregiver-Perceived Energy [ Time Frame: Baseline, Week 2, Week 4, Week 6, and Week 8 ]
  • Change in Parent/Caregiver-Perceived Focus [ Time Frame: Baseline, Week 2, Week 4, Week 6, and Week 8 ]
  • Change in Parent/Caregiver-Perceived Immune Health [ Time Frame: Baseline, Week 2, Week 4, Week 6, and Week 8 ]
  • Change in Parent/Caregiver-Perceived Overall Well-Being [ Time Frame: Baseline, Week 2, Week 4, Week 6, and Week 8 ]

Central Contacts and Locations

Central contacts

Patrick Renner

42424250284hello@citruslabs.com

Locations

Citruslabs

Recruiting

Las Vegas, Nevada, United States, 89118

More Information

Sponsor

Hiya Health

Last update posted

Oct 26, 2026

Last verified

Oct, 2026

Trial information was received from ClinicalTrials.gov and was last updated on 2026-10-27. This information was provided to ClinicalTrials.gov by Hiya Health on 2026-10-26. Recruitment status is synced daily from ClinicalTrials.gov and may not reflect the sponsor's current status. Confirm during your call.